Castration-resistant Prostate Cancer: Adaptation or Clonal Selection? Insight from the EORTC 30891 Trial

被引：2
|
作者：
Tombal, Bertrand [1 ]
机构：
[1] Clin Univ St Luc, Serv Urol, Inst Rech Clin, B-1200 Brussels, Belgium
来源：
EUROPEAN UROLOGY | 2014年 / 66卷 / 05期
关键词：
THERAPY; TUMOR;
D O I：
10.1016/j.eururo.2013.11.047
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：839 / 840
页数：2
相关论文
共 50 条
  • [1] Adaptation and clonal selection models of castration-resistant prostate cancer: Current perspective
    Ahmed, Muhammed
    Li, Long-Cheng
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (04) : 362 - 371
  • [2] Adaptation or selection - Mechanisms of castration-resistant prostate cancer
    Zong Y.
    Goldstein A.S.
    [J]. Nature Reviews Urology, 2013, 10 (2) : 90 - 98
  • [3] Adaptation or selection-mechanisms of castration-resistant prostate cancer
    Zong, Yang
    Goldstein, Andrew S.
    [J]. NATURE REVIEWS UROLOGY, 2013, 10 (02) : 90 - 98
  • [4] Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
    Beltran, Himisha
    Prandi, Davide
    Mosquera, Juan Miguel
    Benelli, Matteo
    Puca, Loredana
    Cyrta, Joanna
    Marotz, Clarisse
    Giannopoulou, Eugenia
    Chakravarthi, Balabhadrapatruni V. S. K.
    Varambally, Sooryanarayana
    Tomlins, Scott A.
    Nanus, David M.
    Tagawa, Scott T.
    Van Allen, Eliezer M.
    Elemento, Olivier
    Sboner, Andrea
    Garraway, Levi A.
    Rubin, Mark A.
    Demichelis, Francesca
    [J]. NATURE MEDICINE, 2016, 22 (03) : 298 - 305
  • [5] Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
    Himisha Beltran
    Davide Prandi
    Juan Miguel Mosquera
    Matteo Benelli
    Loredana Puca
    Joanna Cyrta
    Clarisse Marotz
    Eugenia Giannopoulou
    Balabhadrapatruni V S K Chakravarthi
    Sooryanarayana Varambally
    Scott A Tomlins
    David M Nanus
    Scott T Tagawa
    Eliezer M Van Allen
    Olivier Elemento
    Andrea Sboner
    Levi A Garraway
    Mark A Rubin
    Francesca Demichelis
    [J]. Nature Medicine, 2016, 22 : 298 - 305
  • [6] Therapy selection for metastasized castration-resistant prostate cancer
    von Amsberg, G.
    Steuber, T.
    Lorch, A.
    [J]. ONKOLOGE, 2015, 21 (09): : 825 - +
  • [7] Trial design for metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Fleming, Mark T.
    Hutson, Thomas E.
    Galsky, Matthew D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3647 - 3648
  • [8] DIETHYLSTILBESTROL IN CASTRATION-RESISTANT PROSTATE CANCER OESTROGENS IN CASTRATION-RESISTANT PROSTATE CANCER: BACK TO THE FUTURE?
    Sartor, Oliver
    [J]. BJU INTERNATIONAL, 2012, 110 (11B) : E736 - E736
  • [9] Trial design for metastatic castration-resistant prostate cancer - Reply
    Scher, Howard I.
    Halabi, Susan
    Tannock, Ian F.
    Morris, Michael
    Sternberg, Cora N.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Higano, Celestia
    Bubley, Glenn J.
    Dreicer, Robert
    Petrylak, Daniel P.
    Kantoff, Philip
    Basch, Ethan
    Kelly, Wm Kevin
    Figg, William D.
    Small, Eric J.
    Beer, Tomasz M.
    Wilding, George
    Martin, Alison
    Hussain, Maha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3648 - 3649
  • [10] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
12345